Unilateral inguinal hernia including recurrent inguinal hernia. TAPP, Bupivacaine, preperitoneal, pain
Conditions
Interventions
Intervention group of patient will receive instillation of Bupivacaine onto the preperitoneal space prior mesh application. ,This is a control group of patient will receive instillation of saline as p
Active Comparator Drug,Placebo Comparator Drug
LA instillation group ,Placebo group
Sponsors
Universiti Kebangsaan Malaysia
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. Elective surgery. 2. Unilateral inguinal hernia including recurrent unilateral inguinal hernia. 3. Patients with American Society of Anaesthesia (ASA) score of 2.
Exclusion criteria
Exclusion criteria: 1. Incarceraed or obstructed inguinal hernias. 2. Emergency hernia surgery. 3. ASA score 3 or more. 4. Known allergy to Bupivacaine
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Post operative pain control 1 hour, 4 hour, 12 hour and 24 hour post surgery WHO pain score | — |
Secondary
| Measure | Time frame |
|---|---|
| Amount of analgesic usage within 5 days post surgery Frequency of each analgesic consumed each day post surgery,Date at which patient able to continue activities of daily living comfortably 2 weeks post surgery Date; the duration between surgery date is calculated to see the duration | — |
Countries
Malaysia
Contacts
Public ContactHISYAM HUSIN
UNIVERSITI KEBANGSAAN MALAYSIA
Outcome results
None listed